Company intelligence / Profile preview

生寶生物科技股份有限公司 (HealthBanks Biotech Co., Ltd.)

Taipei City, Taipei, Taiwan0227415468.web66.com.tw ↗

Ownership: Private
Development stage: Commercial

Overview

The company operates the largest private cord blood bank in Hong Kong and Taiwan, with over 10 years as market leader in Hong Kong (>90% market share), providing both umbilical cord blood and tissue storage services. It has provided at least 45 samples for clinical use to date. The laboratory holds multiple international accreditations including AABB, CAP, FACT; it is recognized for its quality management systems (ISO9001/17025/15189) and has won several industry awards

Therapeutic areas: Hematology
Modalities: Cord blood stem cellsMesenchymal stem cells from cord tissue
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on 生寶生物科技股份有限公司 (HealthBanks Biotech Co., Ltd.).

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 生寶生物科技股份有限公司 (HealthBanks Biotech Co., Ltd.).

Explore the full profile